Published

United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The International journal on drug policy
Date: 2022-01-01
Source: PubMed
DOI: 10.1016/j.drugpo.2021.103473
PubMed: 34624734

Authors

Barnett BS Parker SE Weleff J

Watch author

Derived topics and classifications

psilocybin Addiction Clinical Trial Review Article Safety Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Investigation of Psychedelic Effects in Psychoactive SubstancesClinicalTrials.gov · 2026-02-23 Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects: A Placebo-controlled Cross-over Study (DMT BDR-Study).ClinicalTrials.gov · 2025-04-11 Molecular Imaging Study of Harmine/DMT: a Basic Research ApproachClinicalTrials.gov · 2025-03-19 Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over StudyClinicalTrials.gov · 2024-04-25